Evidence map›Paper›PMID 35211511›Full record

ReviewFrontiers in molecular biosciences2022

Inteins as Drug Targets and Therapeutic Tools.

Anil Mathew Tharappel, Zhong Li, Hongmin Li

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Studying Peptide-Metal Ion Complex Structures by Solution-State NMR.International journal of molecular sciences · 2022
    Review
  8. Calcimycin InhibitsACS infectious diseases · 2022
    Article
  9. Journal of fungi (Basel, Switzerland) · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anil Mathew TharappelDepartment of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ, United States.
Zhong LiDepartment of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ, United States.
Hongmin LiDepartment of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ, United States.
University of Arizona · US

Funding

High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosisR01AI161845 · NIAID · UNIVERSITY OF ARIZONA · PI AVRAM, DORINA, LI, HONGMIN · 2021 to 2025
$3.9M
High throughput screening of orthosteric inhibitors of flavivirus proteaseR01AI131669 · NIAID · WADSWORTH CENTER · PI LI, HONGMIN · 2018 to 2022
$2.6M
High throughput screening of the Prp8 intein splicing inhibitors for pathogenic fungiR01AI140726 · NIAID · WADSWORTH CENTER · PI LI, HONGMIN · 2019 to 2022
$2.4M
Neutralizing nanobodies as therapeutics for Dengue virusR21AI140406 · NIAID · WADSWORTH CENTER · PI LAWRENCE, DAVID A, LI, HONGMIN · 2018 to 2019
$460k
Discovery of therapeutics against Cryptococcosis by Repurposing Pharmaceutical LibrariesR21AI141178 · NIAID · WADSWORTH CENTER · PI LI, HONGMIN · 2019 to 2020
$441k
NIAID NIH HHS R01 AI131669NIAID NIH HHS R01 AI140726NIAID NIH HHS R01 AI161845NIAID NIH HHS R21 AI140406NIAID NIH HHS R21 AI141178
6 · The paper itself

Abstract

Multidrug-resistant pathogens are of significant concern in recent years. Hence new antifungal and anti-bacterial drug targets are urgently needed before the situation goes beyond control. Inteins are polypeptides that self-splice from exteins without the need for cofactors or external energy, resulting in joining of extein fragments. Inteins are present in many organisms, including human pathogens such as

Indexed as

anti-microbialdrug targetinhibitorinteintherapeutic tool

Identifiers

PMID35211511
PMCPMC8861304
OpenAlexW4210881775

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.